J. A. Sparano - Concepedia

Author

J. A. Sparano

Montefiore Medical Center

Also Known As

J A Sparano, J SPARANO, J Sparano, J. A. Sparano, J. Sparano, J.A. Sparano, JosephA. Sparano

Publications

570

Citations

H-Index

Concepts

All Affiliations

Montefiore Medical Center Indiana University – Purdue University Indianapolis Albert Einstein College of Medicine Eastern Cooperative Oncology Group Dana-Farber Cancer Institute

About

J. A. Sparano is an author at Montefiore Medical Center specializing in medicine, oncology, and clinical trials.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	328
2	Health Sciences	3	3	61
3	Immunology	3	3	66
4	Neurology	2	2	65
5	Neuroscience	1	1	44

J. A. Sparano

Publications

450

Citations

H-Index

Page 1

	Year	Citations
A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer Kathy D. Miller, William J. Gradishar, Lynn M. Schuchter, Annals of Oncology Surgical OncologyOncologyBreast OncologyAdjuvant MarimastatBreast Cancer	2002	63
Liposomal anthracyclines for breast cancer J. A. Sparano, EP Winer Seminars in Oncology Breast OncologyBreast CancerTumor TargetingAnti-cancer AgentMedicine	2001	50
Paclitaxel (Taxol)/doxorubicin combinations in advanced breast cancer: the Eastern Cooperative Oncology Group experience. George W. Sledge, N. J. Robert, J. A. Sparano, PubMed	1994	49
Genetic associations with taxane-induced neuropathy by a genome-wide association study (GWAS) in E5103. B. P. Schneider, L. Li, Kurt W. Miller, Journal of Clinical Oncology NeurogenomicsGeneticsCancer ManagementGenetic EpidemiologyPathology	2011	44
Phase III study of doxorubicin-cyclophosphamide followed by paclitaxel or docetaxel given every 3 weeks or weekly in operable breast cancer: Results of Intergroup Trial E1199 J. A. Sparano, M. Wang, Simona Di Martino, Journal of Clinical Oncology Surgical OncologyOncologyPaclitaxel 175Breast OncologyCancer Management	2007	40
Eastern Cooperative Oncology Group studies of paclitaxel and doxorubicin in advanced breast cancer. George W. Sledge, N. J. Robert, J. A. Sparano, PubMed	1995	37
Opportunistic Infection and Immunologic Function in Patients With Human Immunodeficiency Virus-Associated Non-Hodgkin's Lymphoma Treated With Chemotherapy J. A. Sparano, Xiao Hu, Peter H. Wiernik, JNCI Journal of the National Cancer Institute	1997	36
PHASE II TRIAL OF INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, & ETOPOSIDE (CDE) IN HIV-ASSOCIATED NON-HODGKIN'S LYMPHOMA (NHL): AN EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG) TRIAL (E1494). J. A. Sparano, S. Lee, Madison C. Williams Chen, JAIDS Journal of Acquired Immune Deficiency Syndromes Lymphoid NeoplasiaMedicineImmunologyHematologyClinical Trials	1999	35
Cerebral infection complicating systemic aspergillosis in acute leukemia: clinical and radiographic presentation J. A. Sparano, Rasim Gucalp, JosefinaF. Llena, Journal of Neuro-Oncology Diagnostic MycologyMedicineHematologyPathologyClinical Mycology	1992	21
Treatment of AIDS-related lymphomas. J. A. Sparano PubMed Primary ImmunodeficiencyLymphoid NeoplasiaTreatment And PreventionImmunodeficienciesImmunology	1995	18

Page 1